Do migrants overreport adherence to highly active antiretroviral therapy?: Results from the french VESPA (ANRS-EN12) national survey [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 5, 2006, Pages 646-647

  Marcellin, Fabienne ^a,b   Carrieri, M Patrizia ^a,b   Peretti Watel, Patrick ^a,b   Bouhnik, Anne Déborah ^a,b   Obadia, Yolande ^a,b   Lert, France ^a   Spire, Bruno ^a,b  

^a INSERM   (France)

^b OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONFIDENCE INTERVAL; CONTROLLED STUDY; DEVELOPING COUNTRY; FRANCE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; STATISTICAL ANALYSIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; EMIGRATION AND IMMIGRATION; FRANCE; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE;

EID: 33746683176     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000223021.93944.be     Document Type: Letter

References (10)

1. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS. 1999;13:1099-1107.
2. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417-1423.
3. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
4. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
5. Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read. 2000;10:177-185.
6. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
7. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31:S123-S127.
8. Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr. 2002;31:S149-S153.
9. Peretti-Watel P, Riandey B, Dray-Spira R, et al. Comment enguêter la population séropositive en France? L"enquête ANRS-EN12-VESPA 2003. Population. 2005;60(4):525-550.
10. Peretti-Watel P, Spire B, Lert F, et al. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug Alcohol Depend. 2006;82(suppl 1):S71-S79.